Interpretive disparity among pathologists in breast sentinel lymph node evaluation

Am J Surg. 2003 Oct;186(4):324-9. doi: 10.1016/s0002-9610(03)00268-x.

Abstract

Background: Immunohistochemical staining on breast sentinel lymph nodes (SLN) is controversial.

Methods: Twenty-five SLN cases were reviewed by 10 pathologists (three academic, seven private) including 5 negative by both hematoxylin and eosin (H&E) and immunohistochemistry, 11 micrometastases (<2 mm) negative by H&E but positive by immunohistochemistry, and 8 micrometastases and 1 macrometastasis (>2 mm) positive for both H&E and immunohistochemistry. Answers included "positive," "negative," and "indeterminate" for each slide.

Results: The mean number of incorrect responses was 6.6 for immunohistochemistry and 5 for H&E. Twelve percent of cases were correct by all 10 pathologists; 80% of positive IHC cases had at least one pathologist score it incorrectly. As tumor cells decrease in number, incorrect responses increase. When tumor cells numbered less than 10, more than 30% of pathologists answered incorrectly.

Conclusions: As tumor cells decrease in number pathologists' ability to recognize them decreases. We propose adding "indeterminate" to "positive" and "negative" when tumor cells number less than 10.

MeSH terms

  • Breast Neoplasms / pathology*
  • Coloring Agents
  • Diagnostic Errors
  • Eosine Yellowish-(YS)
  • Female
  • Hematoxylin
  • Histocytochemistry
  • Humans
  • Immunohistochemistry
  • Lymphatic Metastasis / diagnosis
  • Observer Variation
  • Pathology, Clinical
  • Reproducibility of Results
  • Sentinel Lymph Node Biopsy*

Substances

  • Coloring Agents
  • Eosine Yellowish-(YS)
  • Hematoxylin